{"id":"W4384126750","doi":"10.1158/1078-0432.ccr-23-0731","title":"Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; London Health Sciences Centre; Western University; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Cabazitaxel; Medicine; Prostate cancer; Abiraterone acetate; Prostatectomy; Urology; Neoadjuvant therapy; Interquartile range; Internal medicine; Taxane; Cancer; Oncology; Surgery; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002152379,0.001240893,0.001467701,0.0002533669,0.0002627363,0.001004622,0.0008082765,0.000827527,0.002857431],"category_scores_gemma":[0.001079799,0.0004081493,0.0009155331,0.0003689767,0.0008134763,0.0004155397,0.0002733818,0.002120727,0.0005927529],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007499351,"about_ca_system_score_gemma":0.002344523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001092565,"about_ca_topic_score_gemma":0.003774703,"domain_scores_codex":[0.9993857,0.0003950732,0.00003687735,0.00007622672,0.00005106796,0.00005494479],"domain_scores_gemma":[0.9991102,0.0001725743,0.0002435558,0.0000669315,0.00005744923,0.0003493471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9247606,0.01617538,0.004960008,0.0008423509,0.0009900623,0.00008171886,0.00009556107,0.00114717,0.009501951,0.0001290585,0.001402243,0.03991383],"study_design_scores_gemma":[0.8878202,0.1044275,0.004484744,0.00005543599,0.000468872,0.0001367644,0.00002483932,0.0005217799,0.0009966329,0.00007062399,0.0009795108,0.00001311352],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892814,0.004803913,0.0004131522,0.000575134,0.0001378089,0.002525636,0.000659065,0.00006798575,0.001535862],"genre_scores_gemma":[0.9902092,0.002456604,0.001686033,0.000774559,0.0002597711,0.002178908,0.00108638,0.00001276775,0.001335598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002857431,"threshold_uncertainty_score":0.01138306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1441645215497857,"score_gpt":0.4955546034963854,"score_spread":0.3513900819465997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}